PDCO has been successfully added into Your Stock Email Alerts list.
You can manage your stock email alerts here.
PDCO has been removed from your Stock Email Alerts list.
GuruFocus Financial Strength Rank measures how strong a companys financial situation is. It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
| vs
industry |
vs
history |
||
|---|---|---|---|
| Cash to Debt | 0.675 |
PDCO's Cash to Debt is ranked lower than
2941174% of the 34 Companies in the Global Medical Distribution industry. ( Industry Median: 2.09 vs. PDCO: 0.675 ) |
PDCO'
s 10-Year Cash to Debt Range
Min: 0.29 Max: No Debt Current: 0.68 |
| Equity to Asset | 0.129 |
PDCO's Equity to Asset is ranked lower than
3225803% of the 31 Companies in the Global Medical Distribution industry. ( Industry Median: 0.37 vs. PDCO: 0.129 ) |
PDCO'
s 10-Year Equity to Asset Range
Min: 0.06 Max: 0.65 Current: 0.13 |
| Interest Coverage | 14.1 |
PDCO's Interest Coverage is ranked lower than
3333330% of the 30 Companies in the Global Medical Distribution industry. ( Industry Median: 92.60 vs. PDCO: 14.1 ) |
PDCO'
s 10-Year Interest Coverage Range
Min: 12 Max: 2711 Current: 14.1 |
| F-Score: 5 |
|
| Z-Score: 4.81 |
|
1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank
| vs
industry |
vs
history |
||
|---|---|---|---|
| Operating margin (%) | 10.10 |
PDCO's Operating margin (%) is ranked higher than
70% of the 33 Companies in the Global Medical Distribution industry. ( Industry Median: 5.00 vs. PDCO: 10.10 ) |
PDCO'
s 10-Year Operating margin (%) Range
Min: 8.9 Max: 12.5 Current: 10.1 |
| Net-margin (%) | 6 |
PDCO's Net-margin (%) is ranked higher than
69% of the 32 Companies in the Global Medical Distribution industry. ( Industry Median: 2.90 vs. PDCO: 6 ) |
PDCO'
s 10-Year Net-margin (%) Range
Min: 5.7 Max: 7.6 Current: 6 |
| ROE (%) | 15.5 |
PDCO's ROE (%) is ranked higher than
72% of the 32 Companies in the Global Medical Distribution industry. ( Industry Median: 11.20 vs. PDCO: 15.5 ) |
PDCO'
s 10-Year ROE (%) Range
Min: 14.4 Max: 22.4 Current: 15.5 |
| ROA (%) | 7.8 |
PDCO's ROA (%) is ranked higher than
84% of the 32 Companies in the Global Medical Distribution industry. ( Industry Median: 4.30 vs. PDCO: 7.8 ) |
PDCO'
s 10-Year ROA (%) Range
Min: 7.8 Max: 14.5 Current: 7.8 |
| ROC (Joel Greenblatt) (%) | 57.70 |
PDCO's ROC (Joel Greenblatt) (%) is ranked higher than
77% of the 31 Companies in the Global Medical Distribution industry. ( Industry Median: 27.10 vs. PDCO: 57.70 ) |
PDCO'
s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 53.4 Max: 86.6 Current: 57.7 |
| Revenue Growth (%) | 5.1 |
PDCO's Revenue Growth (%) is ranked lower than
69% of the 16 Companies in the Global Medical Distribution industry. ( Industry Median: 6.90 vs. PDCO: 5.1 ) |
PDCO'
s 10-Year Revenue Growth (%) Range
Min: 5.1 Max: 13.9 Current: 5.1 |
| EBITDA Growth (%) | 3.2 |
PDCO's EBITDA Growth (%) is ranked lower than
5882347% of the 17 Companies in the Global Medical Distribution industry. ( Industry Median: 7.90 vs. PDCO: 3.2 ) |
PDCO'
s 10-Year EBITDA Growth (%) Range
Min: 3.2 Max: 19.9 Current: 3.2 |
| EPS Growth (%) | 3.2 |
PDCO's EPS Growth (%) is ranked lower than
6666660% of the 15 Companies in the Global Medical Distribution industry. ( Industry Median: 8.80 vs. PDCO: 3.2 ) |
PDCO'
s 10-Year EPS Growth (%) Range
Min: 2.8 Max: 17.7 Current: 3.2 |
| Jim Simons 19,207 sh (New) Mario Gabelli 666,298 sh (+25.03%) Donald Yacktman 3,021,650 sh (+0.92%) Bill Frels 1,679,054 sh (+0.21%) | Tom Gayner 146,600 sh (unchged) | John Hussman Sold Out Columbia Wanger 2,294,200 sh (-0.04%) John Keeley 1,098,040 sh (-2.13%) Joel Greenblatt 47,854 sh (-34.54%) Jeremy Grantham 46,900 sh (-39.48%) Paul Tudor Jones 9,300 sh (-43.29%) Steven Cohen 10,430 sh (-73.57%) |
| Jim Simons 247,104 sh (+1186.53%) Mario Gabelli 977,768 sh (+46.75%) Bill Frels 1,704,327 sh (+1.51%) Donald Yacktman 3,025,650 sh (+0.13%) | Columbia Wanger 2,294,200 sh (unchged) Yacktman Fund 2,050,000 sh (unchged) Yacktman Focused Fund 650,000 sh (unchged) | Jeremy Grantham Sold Out Tom Gayner 146,200 sh (-0.27%) John Keeley 1,065,575 sh (-2.96%) Steven Cohen 9,634 sh (-7.63%) Paul Tudor Jones 7,500 sh (-19.35%) Joel Greenblatt 16,669 sh (-65.17%) |
| Joel Greenblatt 122,938 sh (+637.52%) Mario Gabelli 1,419,468 sh (+45.17%) Bill Frels 1,867,145 sh (+9.55%) Steven Cohen 10,171 sh (+5.57%) Donald Yacktman 3,034,650 sh (+0.3%) | Yacktman Fund 2,050,000 sh (unchged) Yacktman Focused Fund 650,000 sh (unchged) | Jim Simons Sold Out Paul Tudor Jones Sold Out Tom Gayner 146,100 sh (-0.07%) John Keeley 1,057,058 sh (-0.8%) Columbia Wanger 1,832,000 sh (-20.15%) |
| Paul Tudor Jones 12,100 sh (New) John Hussman 100,000 sh (New) Jeremy Grantham 26,167 sh (New) Steven Cohen 250,792 sh (+2365.76%) Mario Gabelli 1,553,669 sh (+9.45%) Bill Frels 1,928,667 sh (+3.29%) Donald Yacktman 3,049,500 sh (+0.49%) Columbia Wanger 1,834,400 sh (+0.13%) | Tom Gayner 146,100 sh (unchged) Yacktman Focused Fund 650,000 sh (unchged) Yacktman Fund 2,050,000 sh (unchged) | John Keeley 983,670 sh (-6.94%) Joel Greenblatt 49,681 sh (-59.59%) |
| Guru | Date | Trades | Impact to Portfolio | Price Range * (?) | Current Price | Change from Average | Current Shares | |
|---|---|---|---|---|---|---|---|---|
| Joel Greenblatt | 2013-03-31 | Reduce -59.59% | 0.14% | $34.23 - $38.04 | $ 39.2 | 8% | 49681 | |
| John Hussman | 2013-03-31 | New Buy | 0.14% | $34.23 - $38.04 | $ 39.2 | 8% | 100000 | |
| Joel Greenblatt | 2012-12-31 | Add 637.52% | 0.21% | $32.99 - $36.02 | $ 39.2 | 15% | 122938 | |
| Mario Gabelli | 2012-12-31 | Add 45.17% | 0.11% | $32.99 - $36.02 | $ 39.2 | 15% | 1419468 | |
| Mario Gabelli | 2012-09-30 | Add 46.75% | 0.08% | $33.45 - $36.13 | $ 39.2 | 13% | 977768 | |
| Joel Greenblatt | 2012-09-30 | Reduce -65.17% | 0.08% | $33.45 - $36.13 | $ 39.2 | 13% | 16669 | |
| John Hussman | 2012-06-30 | Sold Out | 0.08% | $32.18 - $34.51 | $ 39.2 | 18% | 0 | |
| Joel Greenblatt | 2012-06-30 | Reduce -34.54% | 0.07% | $32.18 - $34.51 | $ 39.2 | 18% | 47854 | |
| Mario Gabelli | 2012-06-30 | Add 25.03% | 0.03% | $32.18 - $34.51 | $ 39.2 | 18% | 666298 | |
| John Hussman | 2012-03-31 | Reduce -78.98% | 0.23% | $29.33 - $33.23 | $ 39.2 | 32% | 128000 | |
| Joel Greenblatt | 2012-03-31 | Add 51.06% | 0.07% | $29.33 - $33.23 | $ 39.2 | 32% | 73103 | |
| Donald Yacktman | 2011-09-30 | Add 375.4% | 0.55% | $26.87 - $34.04 | $ 39.2 | 32% | 2377000 | |
| Joel Greenblatt | 2011-09-30 | Add 208.45% | 0.17% | $26.87 - $34.04 | $ 39.2 | 32% | 52717 | |
| John Hussman | 2011-06-30 | Reduce -24.45% | 0.11% | $31.64 - $36.8 | $ 39.2 | 16% | 608900 | |
| Joel Greenblatt | 2011-06-30 | Reduce -31.51% | 0.08% | $31.64 - $36.8 | $ 39.2 | 16% | 17091 | |
| James Barrow | 2011-06-30 | Sold Out | 0.01% | $31.64 - $36.8 | $ 39.2 | 16% | 0 | |
| Mario Gabelli | 2011-03-31 | Reduce -22.34% | 0.03% | $30.63 - $34.36 | $ 39.2 | 21% | 440307 | |
| Joel Greenblatt | 2010-12-31 | New Buy | 0.25% | $27.48 - $31.02 | $ 39.2 | 35% | 24669 | |
| James Barrow | 2010-12-31 | Add 52.07% | $27.48 - $31.02 | $ 39.2 | 35% | 99300 | ||
| Donald Yacktman | 2010-09-30 | New Buy | 0.3% | $25.27 - $29.16 | $ 39.2 | 44% | 500000 | |
| James Barrow | 2010-09-30 | New Buy | $25.27 - $29.16 | $ 39.2 | 44% | 65300 | ||
| John Hussman | 2010-06-30 | Add 132.56% | 0.28% | $28.74 - $32.78 | $ 39.2 | 28% | 1000000 | |
| John Hussman | 2010-03-31 | New Buy | 0.24% | $27.98 - $31.24 | $ 39.2 | 31% | 430000 | |
| Tom Gayner | 2010-03-31 | Add 38.42% | 0.07% | $27.98 - $31.24 | $ 39.2 | 31% | 124300 |
More recent guru trades are included for Premium Members only!!| vs
industry |
vs
history |
||
|---|---|---|---|
| P/E(ttm) | 19.70 |
PDCO's P/E(ttm) is ranked lower than
3124997% of the 32 Companies in the Global Medical Distribution industry. ( Industry Median: 20.10 vs. PDCO: 19.70 ) |
PDCO'
s 10-Year P/E(ttm) Range
Min: 9.51 Max: 40.01 Current: 19.7 |
| P/B | 3.03 |
PDCO's P/B is ranked lower than
2941174% of the 34 Companies in the Global Medical Distribution industry. ( Industry Median: 2.18 vs. PDCO: 3.03 ) |
PDCO'
s 10-Year P/B Range
Min: 1.74 Max: 7.31 Current: 3.03 |
| P/S | 1.14 |
PDCO's P/S is ranked lower than
2941174% of the 34 Companies in the Global Medical Distribution industry. ( Industry Median: 0.67 vs. PDCO: 1.14 ) |
PDCO'
s 10-Year P/S Range
Min: 0.64 Max: 3.04 Current: 1.14 |
| PFCF | 16.40 |
PDCO's PFCF is ranked lower than
3703700% of the 27 Companies in the Global Medical Distribution industry. ( Industry Median: 13.50 vs. PDCO: 16.40 ) |
PDCO'
s 10-Year PFCF Range
Min: 9.21 Max: 324 Current: 16.4 |
| EV-to-EBIT | 12.76 |
PDCO's EV-to-EBIT is ranked lower than
3124997% of the 32 Companies in the Global Medical Distribution industry. ( Industry Median: 12.19 vs. PDCO: 12.76 ) |
PDCO'
s 10-Year EV-to-EBIT Range
Min: 6.7 Max: 25.1 Current: 12.76 |
| PEG | 3.58 |
PDCO's PEG is ranked lower than
6666660% of the 15 Companies in the Global Medical Distribution industry. ( Industry Median: 1.62 vs. PDCO: 3.58 ) |
PDCO'
s 10-Year PEG Range
Min: 0.93 Max: 4.07 Current: 3.58 |
| Shiller P/E | 20.33 |
PDCO's Shiller P/E is ranked lower than
100% of the Companies in the Global Medical Distribution industry. ( Industry Median: vs. PDCO: 20.33 ) |
PDCO'
s 10-Year Shiller P/E Range
Min: 11.11 Max: 60.69 Current: 20.33 |
| vs
industry |
vs
history |
||
|---|---|---|---|
| Dividend Yield | 1.48 |
PDCO's Dividend Yield is ranked lower than
3571425% of the 28 Companies in the Global Medical Distribution industry. ( Industry Median: 1.47 vs. PDCO: 1.48 ) |
PDCO'
s 10-Year Dividend Yield Range
Min: 0.31 Max: 1.64 Current: 1.48 |
| Dividend Payout | 0.3 |
PDCO's Dividend Payout is ranked lower than
3999996% of the 25 Companies in the Global Medical Distribution industry. ( Industry Median: 0.40 vs. PDCO: 0.3 ) |
PDCO'
s 10-Year Dividend Payout Range
Min: 0.06 Max: 0.26 Current: 0.3 |
| Yield on cost (5-Year) | 1.50 |
PDCO's Yield on cost (5-Year) is ranked lower than
3571425% of the 28 Companies in the Global Medical Distribution industry. ( Industry Median: 1.57 vs. PDCO: 1.50 ) |
PDCO'
s 10-Year Yield on cost (5-Year) Range
Min: 0.31 Max: 1.64 Current: 1.5 |
| Share Buyback Rate | 1.6 |
PDCO's Share Buyback Rate is ranked lower than
14285700% of the 7 Companies in the Global Medical Distribution industry. ( Industry Median: 0.90 vs. PDCO: 1.6 ) |
PDCO'
s 10-Year Share Buyback Rate Range
Min: 4 Max: -0.4 Current: 1.6 |
| vs
industry |
vs
history |
||
|---|---|---|---|
| Price/Net Current Asset Value | 8.3 |
PDCO's Price/Net Current Asset Value is ranked lower than
3030300% of the 33 Companies in the Global Medical Distribution industry. ( Industry Median: 4.10 vs. PDCO: 8.3 ) |
PDCO'
s 10-Year Price/Net Current Asset Value Range
Min: 5 Max: 20.8 Current: 8.3 |
| Price/Tangible Book | 11.8 |
PDCO's Price/Tangible Book is ranked lower than
3225803% of the 31 Companies in the Global Medical Distribution industry. ( Industry Median: 2.60 vs. PDCO: 11.8 ) |
PDCO'
s 10-Year Price/Tangible Book Range
Min: 5.5 Max: 49.1 Current: 11.8 |
| Price/DCF (Projected) | 1.1 | ||
| Price/Median PS Value | 0.7 |
PDCO's Price/Median PS Value is ranked lower than
3124997% of the 32 Companies in the Global Medical Distribution industry. ( Industry Median: 1.20 vs. PDCO: 0.7 ) |
PDCO'
s 10-Year Price/Median PS Value Range
Min: 0.5 Max: 1.7 Current: 0.7 |
| Price/Peter Lynch Fair Value | 3.3 |
PDCO's Price/Peter Lynch Fair Value is ranked lower than
3063% of the 8 Companies in the Global Medical Distribution industry. ( Industry Median: 1.30 vs. PDCO: 3.3 ) |
PDCO'
s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.9 Max: 3 Current: 3.3 |
| Price/Graham Number | 3.2 |
PDCO's Price/Graham Number is ranked lower than
3333330% of the 30 Companies in the Global Medical Distribution industry. ( Industry Median: 1.80 vs. PDCO: 3.2 ) |
PDCO'
s 10-Year Price/Graham Number Range
Min: 2.4 Max: 8.6 Current: 3.2 |
| Earnings Yield (Greenblatt) | 7.80 |
PDCO's Earnings Yield (Greenblatt) is ranked lower than
63% of the 32 Companies in the Global Medical Distribution industry. ( Industry Median: 8.20 vs. PDCO: 7.80 ) |
PDCO'
s 10-Year Earnings Yield (Greenblatt) Range
Min: 4 Max: 14.9 Current: 7.8 |
| Forward Rate of Return (Yacktman) | 8.7 |
PDCO's Forward Rate of Return (Yacktman) is ranked lower than
7142850% of the 14 Companies in the Global Medical Distribution industry. ( Industry Median: 9.24 vs. PDCO: 8.7 ) |
PDCO'
s 10-Year Forward Rate of Return (Yacktman) Range
Min: 9.5 Max: 28.2 Current: 8.7 |
| Industry: | Medical Distribution | |
|---|---|---|
| Compare: | ABC, MCK, CAH, SHTDF, HSIC | |
| Traded in other countries: | PD2.Germany |
| Patterson Cos Posts In-Line Earnings - Analyst Blog May 23 2013 - ZACKS |